These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17681547)
1. Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects. Florent-Béchard S; Malaplate-Armand C; Koziel V; Kriem B; Olivier JL; Pillot T; Oster T J Neurol Sci; 2007 Nov; 262(1-2):27-36. PubMed ID: 17681547 [TBL] [Abstract][Full Text] [Related]
2. The essential role of lipids in Alzheimer's disease. Florent-Béchard S; Desbène C; Garcia P; Allouche A; Youssef I; Escanyé MC; Koziel V; Hanse M; Malaplate-Armand C; Stenger C; Kriem B; Yen-Potin FT; Olivier JL; Pillot T; Oster T Biochimie; 2009 Jun; 91(6):804-9. PubMed ID: 19303044 [TBL] [Abstract][Full Text] [Related]
3. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506 [TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease. Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184 [TBL] [Abstract][Full Text] [Related]
5. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387 [TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence? Cunnane SC; Chouinard-Watkins R; Castellano CA; Barberger-Gateau P Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):61-70. PubMed ID: 22575581 [TBL] [Abstract][Full Text] [Related]
8. Effects of beta-amyloid on behavioral and amino acids spectrum in rats' brain and their modulation by embryonic proteins. Yenkoyan K; Safaryan K; Navasardyan G; Mkrtchyan L; Aghajanov M Neurochem Int; 2009; 54(5-6):292-8. PubMed ID: 19121356 [TBL] [Abstract][Full Text] [Related]
9. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish. Pauwels EK; Volterrani D; Mariani G; Kairemo K Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365 [TBL] [Abstract][Full Text] [Related]
10. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Calon F; Cole G Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):287-93. PubMed ID: 18037281 [TBL] [Abstract][Full Text] [Related]
12. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756 [TBL] [Abstract][Full Text] [Related]
13. Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease. Plourde M; Fortier M; Vandal M; Tremblay-Mercier J; Freemantle E; Bégin M; Pifferi F; Cunnane SC Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):301-8. PubMed ID: 18036804 [TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice. Oster T; Pillot T Biochim Biophys Acta; 2010 Aug; 1801(8):791-8. PubMed ID: 20211757 [TBL] [Abstract][Full Text] [Related]
15. Food for thought: essential fatty acid protects against neuronal deficits in transgenic mouse model of AD. Mucke L; Pitas RE Neuron; 2004 Sep; 43(5):596-9. PubMed ID: 15339638 [TBL] [Abstract][Full Text] [Related]
16. Current and future therapy in Alzheimer's disease. van Marum RJ Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144 [TBL] [Abstract][Full Text] [Related]
17. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512 [TBL] [Abstract][Full Text] [Related]